Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

The Daily AI Show

What Did We Just Say About AI?: It's Our Bi-Weekly Recap Show for Feb 9th, 2024

09 Feb 2024

Description

In this bi-weekly recap episode, Beth, Andy, Karl, Jyunmi, and Brian looked back at the last 2 weeks of shows and talked about new insights, news, and viewer comments. The episode covered a wide array of topics, from the transition between Google's BARD to its advanced model Gemini, the potential of GPT-5 towards achieving artificial general intelligence, to the innovative applications of graph neural networks. Additionally, it touched on critical issues like deepfakes, highlighting legislative efforts and technological solutions to combat AI-generated misinformation, and the implications for digital content authenticity. Key Points Discussed: Transition from BARD to Gemini: The hosts discuss Google's shift to Gemini, emphasizing its significance in the AI domain and its potential to set new benchmarks. GPT-5 and Artificial General Intelligence: The conversation includes insights into GPT-5's capabilities, suggesting it as a step towards achieving artificial general intelligence through the use of graph neural networks. Deepfakes and Legislative Measures: The episode addresses the growing concern over deepfakes, discussing recent legislative measures and technological solutions such as AI-generated robocall bans and provenance systems for digital content to ensure authenticity and combat misinformation. AI in Healthcare: Highlighting AI's transformative potential in healthcare, particularly in cancer research, the hosts share optimism about AI's role in improving diagnoses, treatment personalization, and drug effectiveness evaluation.

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.